Cadila Pharmaceuticals, one of India’s top global drug manufacturers, has officially entered the Asia Book of Records. The prestigious honor was awarded following a massive nationwide campaign that analyzed the handwriting of 14,040 medical professionals.

Launched in August 2026, the campaign engaged physicians through a graphology-based exploration of their personality traits. Participating doctors were invited to write "ACILOC RD" three times on a prescription pad. Certified handwriting experts then analyzed these samples to identify distinctive writing patterns, translating them into personalized psychological insights for each clinician.

This initiative honors doctors who consistently prioritize patient care over their own well-being. Utilizing the prescription pad—a powerful symbol of hope and human connection in healthcare—the campaign encouraged physicians to pause and reflect on their own unique journeys. As a token of gratitude, every participating doctor received a certificate of appreciation.

Commenting on the milestone, Rajbir Sandhu, Chief Operating Officer – Magna, Cadila Pharmaceuticals, said, "Doctors work selflessly to care for society, often overlooking their own personal traits and well-being. A handwritten prescription carries reassurance and cure for a patient. Through this initiative, we wanted to celebrate the individuals behind those prescriptions, acknowledge their dedication, and offer a meaningful experience of self-discovery."

The recognition marks another milestone in Cadila Pharmaceuticals’ ongoing corporate journey. Beyond manufacturing affordable, high-quality therapeutics worldwide, the campaign reflects the company’s core commitment to extending care beyond conventional medicine and strengthening its bond with the healthcare community.